Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 26;8(6):e2869.
doi: 10.1371/journal.pntd.0002869. eCollection 2014 Jun.

Visceral Leishmaniasis and HIV coinfection in East Africa

Affiliations
Review

Visceral Leishmaniasis and HIV coinfection in East Africa

Ermias Diro et al. PLoS Negl Trop Dis. .

Abstract

Visceral Leishmaniasis (VL) is an important protozoan opportunistic disease in HIV patients in endemic areas. East Africa is second to the Indian subcontinent in the global VL caseload and first in VL-HIV coinfection rate. Because of the alteration in the disease course, the diagnostic challenges, and the poor treatment responses, VL with HIV coinfection has become a very serious challenge in East Africa today. Field experience with the use of liposomal amphotericin B in combination with miltefosine, followed by secondary prophylaxis and antiretroviral drugs, looks promising. However, this needs to be confirmed through clinical trials. Better diagnostic and follow-up methods for relapse and prediction of relapse should also be looked for. Basic research to understand the immunological interaction of the two infections may ultimately help to improve the management of the coinfection.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Map of East Africa showing the geographic distribution of visceral leishmaniasis.
Map taken from “Malaria Consortium; Leishmaniasis control in eastern Africa: Past and present efforts and future needs. Situation and gap analysis, November 2010” .

References

    1. van Griensven J, Diro E (2012) Visceral leishmaniasis. Infect Dis Clin North Am 26: 309–322 10.1016/j.idc.2012.03.005 - DOI - PubMed
    1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671 10.1371/journal.pone.0035671 - DOI - PMC - PubMed
    1. Seaman J, Mercer AJ, Sondorp E (1996) The epidemic of visceral leishmaniasis in western upper Nile, Southern Sudan: Course and impact from 1984 to 1994. Int J Epidemiol 25: 862–871. - PubMed
    1. Olivier M, Badaro R, Medrano FJ, Moreno J (2003) The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann Trop Med Parasitol 97 Suppl 1: 79–98 10.1179/000349803225002561 - DOI - PubMed
    1. Alvar J, Aparicio P, Aseffa A, den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334–359 10.1128/CMR.00061-07 - DOI - PMC - PubMed

Publication types

MeSH terms